This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of complex molecules, particularly in the development of active pharmaceutical ingredients (APIs). Its structure, featuring a difluorophenyl group and a tert-butoxycarbonyl (Boc) protecting group, makes it valuable in the production of drugs targeting specific biological pathways, such as enzyme inhibitors or receptor modulators. The Boc group can be selectively removed under mild conditions, allowing for further functionalization in multi-step synthetic processes. Additionally, the difluorophenyl moiety often contributes to enhanced binding affinity and metabolic stability in drug candidates, making this chemical a key building block in medicinal chemistry.